The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton
AUTOR(ES)
Tong, Xiao
FONTE
The National Academy of Sciences of the USA
RESUMO
The E6 oncoprotein of bovine papillomavirus type 1 (BPV-1) has been shown to transform cells through a p53-independent pathway, but its transforming mechanism is unknown. Here we demonstrate in vitro and in vivo interactions between BPV-1 E6 and the focal adhesion protein paxillin. The ability of BPV-1 E6 to complex with paxillin correlated with its ability to transform; E6 mutant proteins impaired in their transformation function also were impaired in their abilities to bind paxillin. E6 binding to paxillin also may contribute to the carcinogenic potential of the human papillomavirus (HPV); we were able to show in vitro binding of paxillin to the E6 proteins of the cancer-associated type HPV 16 but not of the nononcogenic types 6 and 11. The association of E6 with paxillin was affected by depolymerization of the actin fiber network, and overexpression of BPV-1 E6 led to disruption of actin fiber formation. Disruption of the actin cytoskeleton is a characteristic of many transformed cells, and, in BPV-1 transformed cells, may be mediated by BPV-1 E6 through its interaction with paxillin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=20736Documentos Relacionados
- Identification of a Second Transforming Function in Bovine Papillomavirus Type 1 E6 and the Role of E6 Interactions with Paxillin, E6BP, and E6AP
- Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein.
- Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3
- Mutational analysis of bovine papillomavirus E6 gene.
- Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.
